These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36439113)

  • 1. A recombinant
    Babayeva M; Tabynov K; Nurpeisov T; Fomin G; Renukaradhya GJ; Petrovsky N; Tabynov K
    Front Immunol; 2022; 13():983621. PubMed ID: 36439113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of
    Tabynov K; Babayeva M; Nurpeisov T; Fomin G; Nurpeisov T; Saltabayeva U; Renu S; Renukaradhya GJ; Petrovsky N; Tabynov K
    Front Immunol; 2022; 13():828690. PubMed ID: 35371056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemisia pollen allergy in China: Component-resolved diagnosis reveals allergic asthma patients have significant multiple allergen sensitization.
    Gao Z; Fu WY; Sun Y; Gao B; Wang HY; Liu M; Luo FM; Zhou X; Jin J; Zhao L; Wu S; Liu Y; Wu L; Wang X; Tang NB; Guo BH; Feng Y; Zhou JY; Gadermaier G; Ferreira F; Versteeg SA; van Ree R
    Allergy; 2019 Feb; 74(2):284-293. PubMed ID: 30155917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice.
    Ma WJ; Bao MJ; Zhu JP; Yao HY; Xie YC; Guan Y; Li FF; Dong XW; Zheng YM; Xie QM
    Vaccine; 2012 Feb; 30(8):1437-44. PubMed ID: 22240342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy.
    Rask C; Lund L; Lund G; Heydenreich B; Wurtzen P; Bellinghausen I; Saloga J; Lund K
    Clin Exp Allergy; 2012 Sep; 42(9):1356-68. PubMed ID: 22925322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Art v4.01 protein produces immunological tolerance by subcutaneous immunotherapy in a wormwood pollen-driven allergic asthma female mouse model.
    Wang T; Chi J; Li Z; Zhang Y; Wang Y; Ding M; Zhou B; Gui J; Li Q
    PLoS One; 2024; 19(6):e0280418. PubMed ID: 38941291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients.
    Oberhuber C; Ma Y; Wopfner N; Gadermaier G; Dedic A; Niggemann B; Maderegger B; Gruber P; Ferreira F; Scheiner O; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2008; 145(2):94-101. PubMed ID: 17823540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum immunoglobulin E reactivity to cross-reacting panallergen components in north-eastern Poland patients pollen sensitized.
    Kowal K; Pampuch A; Sacharzewska E; Swiebocka E; Siergiejko Z; Siergiejko G; Chruszcz M; DuBuske L
    Allergy Asthma Proc; 2020 May; 41(3):183-191. PubMed ID: 32375962
    [No Abstract]   [Full Text] [Related]  

  • 12. Artemisia and Ambrosia hypersensitivity: co-sensitization or co-recognition?
    Asero R; Wopfner N; Gruber P; Gadermaier G; Ferreira F
    Clin Exp Allergy; 2006 May; 36(5):658-65. PubMed ID: 16650052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An epicutaneous therapeutic pollen-allergen extract delivery system in an allergic rhinitis mouse model: based on allergen loading on DC-specific aptamers conjugated nanogolds.
    Pordel S; Haghnavaz N; Rezaee M; Shobeiri SS; Ansari B; Dashti M; Moghadam M; Khorrami M; Sankian M
    Immunol Res; 2024 Jun; 72(3):460-475. PubMed ID: 38091227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.
    Spertini F; DellaCorte G; Kettner A; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Reymond C
    J Allergy Clin Immunol; 2016 Jul; 138(1):162-8. PubMed ID: 27373329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine.
    Vrtala S; Grote M; Ferreira F; Susani M; Stocker B; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1995; 107(1-3):290-4. PubMed ID: 7613152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice.
    Airouche S; Beltrami V; Fleury S; Batard T; Bordas-Le Floch V; Stegmann T; Amacker M; Kettner A; Mascarell L
    Clin Exp Allergy; 2021 Feb; 51(2):339-349. PubMed ID: 33368719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study.
    Florido-López JF; Andreu-Balaguer C; Escudero C; Seoane-Rodríguez M; Hernández M; Navarro-Seisdedos LÁ; Torrecillas-Toro M; Anton-Girones M; Herrero-Lifona L; Brugaletta D; Macías J; Pineda R; Lara MÁ; López-Caballero J; Rojas MJ
    World Allergy Organ J; 2020 Dec; 13(12):100487. PubMed ID: 33376572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum specific IgE levels with asthma in autumn pollen-induced allergic rhinitis: A retrospective analysis.
    Cui L; Yin J
    J Asthma; 2019 May; 56(5):505-511. PubMed ID: 29667465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.
    Zieglmayer P; Focke-Tejkl M; Schmutz R; Lemell P; Zieglmayer R; Weber M; Kiss R; Blatt K; Valent P; Stolz F; Huber H; Neubauer A; Knoll A; Horak F; Henning R; Valenta R
    EBioMedicine; 2016 Sep; 11():43-57. PubMed ID: 27650868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.